American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) shared a post on LinkedIn:
“We’re excited to welcome Melinda Aldrich to the ACS National Lung Cancer Roundtable Steering Committee.
Dr. Aldrich is a nationally recognized leader in lung cancer screening, risk prediction, and health equity, whose work has helped shape U.S. Preventive Services Task Force lung cancer screening guidelines. Her research bridges population science and implementation, ensuring evidence leads to real world impact.
‘I joined the ACS NLCRT Steering Committee because its mission to create lung cancer survivors aligns closely with my two decades of research in lung cancer prevention, screening, and outcomes,’ said Dr. Aldrich. ‘I hope to help shape forward looking strategies that translate evidence into meaningful improvements in care.’
As part of the ACS NLCRT Steering Committee, Dr. Aldrich brings deep expertise in early detection and a strong commitment to advancing equitable, data driven screening strategies nationwide.”
Other articles about American Cancer Society on OncoDaily.